In vitro studies indicate that oxidatively modified low density lipoprotein (oxLDL) promotes leukocyte adhesion to the vascular endothelium, a constant feature of early atherogenesis. Using intravital fluorescence microscopy in the dorsal skinfold chamber model in awake Syrian golden hamsters, we studied whether (a) oxLDL elicits leukocyte/endothelium interaction in vivo, and whether (b) leukotrienes play a mediator role in this event.
Introduction
The activation of circulating leukocytes and their adhesion to the microvascular endothelium in response to various noxious stimuli characterize the first step in the initiation of an acute inflammatory response (1) and the microvascular manifestation of ischemia/reperfusion injury (2) . Through the action of degranulation products, adherent leukocytes induce vascular hyperpermeability and contribute to microvascular injury.
The adhesion of leukocytes to the arterial endothelium in areas of increased macromolecular permeability has also been identified as one of the earliest events in atherogenesis (3) . Based on epidemiological studies and in vitro experiments, LDL, in particular after oxidative modification, has been asso-ciated with enhanced leukocyte recruitment and adhesion to the vascular endothelium (4) (5) (6) .
It has been shown that oxidatively modified LDL (oxLDL)', but not native LDL, stimulates cultured macrophages to generate products of both the cyclooxygenase and the lipoxygenase pathway ofarachidonate metabolism (7) . Leukotrienes, metabolites ofarachidonate produced in the 5-lipoxygenase pathway, initiate many of the vascular actions of oxLDL. Leukotriene (LT)B4, one of the most powerful chemotactic substances known, stimulates the adhesion of leukocytes to the endothelial lining and their emigration across the endothelial wall (8) .
The cysteinyl leukotrienes LTC4, LTD4, and LTE4 have been implicated in the alteration of vascular permeability inducing macromolecular leakage and interstitial edema (9) .
These considerations lead us to propose that oxLDL promotes atherogenesis through leukotriene-mediated leukocyte adhesion to the vascular endothelium. We have recently developed an animal model that allows us to investigate leukocyte/ endothelium interaction in response to systemic administration of oxLDL using intravital fluorescence microscopy in the microcirculation ofstriated muscle in hamsters (10) . Using this model and the highly specific leukotriene biosynthesis inhibitor MK-886 (11) , which possesses no unspecific antioxidant effects, we demonstrate in this study that leukotrienes play an essential role in mediating the vascular actions of oxLDL.
Methods
Lipoproteins. Whole blood was collected from healthy human subjects (20-30 yr of age) into tubes containing 1.5 mg dipotassium EDTA/ml blood. LDL fractions were isolated by density gradient centrifugation (12) . LDL density cut was d = 1.045-1.065 g/ml. LDL stock suspensions containing EDTA were stored (40C under argon in the dark) for a maximum of 7 d. Before oxidative modification of LDL, EDTA was removed by chromatography on Sephadex columns (PD-l0, Sephadex G-25M; Pharmacia Fine Chemicals, Uppsala, Sweden). Cholesterol content was determined by Cholesterin Monotest (Boehringer Mannheim GmbH, Mannheim, Germany). LDL suspension was diluted by PBS, without Ca++ and Mg", pH 7.3 (Sigma Chemical Co., Deisenhofen, Germany) to reach a final LDL-cholesterol concentration of 0.85 mg/ml. Autooxidative modification of LDL was achieved by incubation of the LDL suspension (1-1.5 ml) in 7.5 JUM Cull (CUSO4, M, 249.68; E. Merck, Darmstadt, Germany) for 6 h in a water bath at 37°C (13) . Immediately after oxidative modification, oxLDL was injected intravenously as a bolus into the hamsters via permanent jugular catheters (4 mg LDL-cholesterol/kg body wt). Control experiments were performed by injecting native LDL prepared without Cull during incubation.
Catignani (14) using a C18 reversed phase column (4 x 250 mm; particle size 5 Mm) with 98:2 methanol/H20 as mobile phase. LDL-tocopherol was detected by fluorescence (Xex = 295 nm, Xem = 325 nm) and quantified by using a-and -y-tocopherol as a standard. The y-tocopherol peak could theoretically represent f3-tocopherol having the same retention time. Dl-a-tocopherol acetate (Sigma Chemical Co., Deisenhofen) was taken as an internal standard and determined in parallel on a second channel by UV measurement at 280 nm. Not detectable values were below 0.02 Ag a-tocopherol and below 0.002 ,g y-tocopherol.
Fatty acid determinations were performed by capillary gas chromatography as previously described (15) . Lipoperoxides were determined according to El-Saadani et al. (16) . Electrophoretic mobility of LDL and oxLDL was assessed on 0.83% agarose gels. The Rf value is defined as the distance of the LDL spot center from the start point divided by the according distance of the bromphenol blue stained solvent front.
Animal model. For intravital fluorescence microscopy ofthe microvasculature of striated skin muscle, we used the dorsal skinfold chamber preparation in Syrian golden hamsters (17, 18) . This model allows in the awake animal the quantification of leukocyte/endothelium interaction, microvessel diameter, and red cell velocity in arterioles and postcapillary venules of the striated muscle contained within the observation window.
Operative technique. Syrian golden hamsters (6-8 wk old, weighing 60-80 g) were anesthetized by intraperitoneal injection of pentobarbital (60 mg/kg body wt). The entire back of the animals was shaven and two titanium frames were implanted so as to sandwich the extended double layer of the skin. One layer was completely removed in a circular area of 15 mm in diameter and the remaining layer, consisting of epidermis, subcutaneous tissue, and the thin striated skin muscle was covered with a cover slip incorporated in one of the frames. Indwelling venous and arterial catheters were inserted in the jugular vein and the carotic artery, respectively, passed subcutaneously to the dorsal side of the neck, and sutured to the titanium frames. The animals tolerated the dorsal skinfold chambers well and showed no signs of discomfort. In particular, no effect on sleeping and feeding habits was noticed.
Intravital fluorescence microscopy. A recovery period of 48-72 h between implantation ofthe observation chamber and the microscopic investigation was allowed to eliminate the effects of anesthesia and surgical trauma on the microvasculature. Muscle arterioles ,m in diameter) were chosen for investigation, as well as postcapillary and collecting venules Am in diameter), since these vessel segments are considered the major site of interaction between leukocytes and the endothelium in response to noxious stimuli (1). Leukocyte/endothelium interaction, vessel diameter, and red cell velocity were assessed in four to six vessel segments per observation chamber in awake animals. The identical vessel segments were examined before and over the time course after injection ofnative LDL and oxLDL using a computer-controlled stepping motor-driven platform. For visualization of leukocytes, the in vivo fluorescent marker acridine orange was infused intravenously at a constant rate of 0.5 mg/kg per min. The microscopic images (x25 water immersion objective, total magnification: 560) were recorded on videotape and analyzed off-line using a computer-assisted microcirculation analysis system (19) . Sticking leukocytes are given as number of cells per square millimeter of vessel surface as calculated from diameter and length of the vessel segment studied (200 Mm).
Leukotriene inhibition. The highly selective inhibitor of 5-lipoxy-
intravenously as a bolus of 20 ,mol/kg 30 min before injection of oxLDL. Control animals received equivalent volumes of drug vehicle: 1% hamster albumin (Sigma Chemical Co., Deisenhofen) and 0.9% benzyl alcohol in 0.9% saline, pH 7.5, 21 IC. Effective plasma levels of MK-886 were ascertained by the measurement of LTB4 generation in whole blood after ex vivo stimulation with the calcium ionophore A23 187 according to Tateson et al. (20) . Electron microscopy. 15 min after injection of oxLDL, the animals were anesthetized with pentobarbital and fixed by retrograde perfusion through the abdominal aorta for 5 min. The fixation medium contained 2.5% glutaraldehyde and 0.05% CaCi in 0. 
Results
Verification ofLDL oxidation. The oxidation of LDL is a complex process during which numerous chemical and functional properties of LDL are altered (21) . The degradation of polyunsaturated fatty acids by lipid peroxidation is preceded by the loss ofendogenous antioxidants and the formation oflipid peroxides is temporally associated with the degradation ofpolyunsaturated fatty acids. To verify whether these changes had occurred in the LDL, oxidatively modified under the conditions in our experiment (7.5 pm Cu", 6 h, 370C) we assessed the content of tocopherols, the degradation of polyunsaturated fatty acids, the relative electrophoretic mobility in agarose gels (Rf), and the formation of lipoperoxides in native LDL and in oxLDL. a-tocopherol and y-tocopherol, the major antioxidants in LDL (21) , which have been observed to disappear within 6 h under similar incubation conditions (22) , dropped from 3.6±0.8,ug/ml and 0.4±0.2 Ag/ml, respectively, to values below the detection limits. The antioxidant capacity being no longer sufficient to protect the polyunsaturated fatty acids from oxidation, the weight percent of total polyunsaturated fatty acids dropped from 43.2±3.0 to 13.4±7.8 (P < 0.02, MannWhitney test) and the ratio of saturated to cis-unsaturated fatty acids increased from 0.4±0.2 to 1.0±0.2 (P < 0.02, MannWhitney test). The electrophoretic mobility ofthe LDL on agarose gel increased (native LDL: Rf = 0.17±0.08 vs. oxLDL Rf = 0.70±0.16, P < 0.02, Mann-Whitney test), reflecting increased negative surface charge (22) . Finally, lipid peroxidation was confirmed by the demonstration of increased lipoperoxide formation (native LDL: 0.06±0.02 ,umol/ml vs. oxLDL: 0.31±0.04,umol/ml, P < 0.02, Mann-Whitney test).
Microcirculatory changes after injection of oxLDL. While under normal conditions, represented by the baseline situation, the majority ofleukocytes did not interact with the microvascular endothelium, the injection of oxLDL elicited an immediate onset of leukocyte rolling along the endothelial lining and subsequent firm adhesion to the endothelium of arterioles and postcapillary venules, preferentially at vessel bifurcations ( Figs. 1 and 2) . No increase in leukocyte/endothelium interaction was observed after injection of native LDL (Fig. 2) . Differences in the total number of sticking leukocytes between venules and arterioles (Fig. 2) are most likely due to differences in local shear force conditions with low shear forces prevailing in venules and high shear forces in arterioles.
Pretreatment ofthe animals for 30 min with the inhibitor of leukotriene biosynthesis, MK-886, prevented the induction of leukocyte adhesion to the microvascular endothelium (Fig. 2) . This effect was not due to local microhemodynamic changes since neither blood pressure and heart rate, nor vessel diameter and red cell velocity were affected by MK-886 (data not shown).
Electronmicroscopic findings. The concept that all leukocyte subpopulations were likewise affected by the injection of (Fig. 3 ).
Total and differential leukocyte counts. Since acridine orange intercalates with double-stranded DNA and therefore stains all leukocytes without differentiating between the various subpopulations, it is not possible to identify by fluorescence microscopy whether the adherent cells are monocytes, PMNs, or lymphocytes, nor is it possible to discern whether the adherent leukocytes eventually emigrated from the blood stream or reentered the circulation. To find out whether one or several leukocyte subpopulations were preferentially affected by the adhesion-promoting effect of oxLDL, we performed total and differential leukocyte counts at various times after injection of oxLDL. The total leukocyte count dropped by 34% 5 min after injection and remained at that low level throughout the entire follow-up period (Fig. 4) . No changes in total leukocyte count were observed in seven animals following injection of native LDL (data not shown). In the first 10 min after injection of oxLDL, no changes occurred in differential leukocyte counts, indicating that all leukocyte subpopulations were likewise affected by the adhesion-promoting action of oxLDL (Fig. 4) 'C~1: a steady increase in juvenile PMNs presumably in response to the global leukopenia, and a reduction in lymphocytes that might indicate that this leukocyte subpopulation was preferentially retained in the microcirculation (Fig. 4) . The fact that total leukocyte counts remained low over the entire follow-up period suggests that the majority of adherent leukocytes did not reenter the circulation but did emigrate from the blood stream.
Discussion
The principal result ofthis study is that intravenous administration of oxLDL elicits leukocyte/endothelium interaction in arterioles and postcapillary venules and that this event depends on 5-lipoxygenase activity.
Leukocyte adhesion to the endothelium at sites of enhanced vascular permeability is a constant finding in long-term cholesterol feeding experiments on various laboratory animals (3). Yet, due to the chronicity of these experiments and the multifactor etiology of atherosclerosis, it was not possible to investigate the effects of single pathogens or mediators on leukocyte/endothelium interaction as the initial event of atherogenesis. This task has been met in the applied model, which allows us to investigate leukocyte/endothelium interaction in both arterioles and postcapillary venules in response to the patho-physiological stimulus oxLDL (10) , which has been identified in plasma (23) and atherosclerotic lesions (24). In this study we injected oxLDL that had been oxidized by incubation (370C) for 6 h in 7.5 MM Cu++ to mimic the modification of LDL as induced by endothelial cells (13) . After this period of time, tocopherols had been used and phospholipid peroxidation had resulted in the degradation of polyunsaturated fatty acids and the formation of lipid peroxides.
Intravenous injection of thus modified LDL, but not of 12 Lehr, Hilbner, Finckh, Angermiller, Nolte, Beisiegel, Kohlschutter, and Messmer identical amounts of native LDL, elicited leukocyte rolling along the endothelial lining within a few minutes after injection, followed by a gradual increase in leukocyte adhesion to the endothelium of both arterioles and postcapillary venules, preferentially at vessel bifurcations ( Figs. 1 and 2 ). This adhesion of leukocytes within the microcirculatory network was associated with a marked drop in total leukocyte count (Fig. 4) , suggesting that the phenomenon occurred not only in the investigated muscle tissue, but also in other organs. It is generally accepted that besides smooth muscle cells, the nonmyogenic cell population in atherosclerotic lesions consists of foam cells of monocytic origin. A chemotactic factor for monocytes produced from endothelial cells after stimulation with oxLDL in vitro has been identified (25) . While monocytes differentiate into tissue macrophages and are easily identifiable in histologic sections no morphologic correlate supports the involvement of other nonmyogenic cells in advanced atherosclerotic lesions. On the other hand, cholesterol feeding studies on various laboratory animals showed that not only monocytes, but also lymphocytes and granulocytic cells readily adhered to the vascular endothelium (26) . This observation is supported by the results of our study. Although the fluorescence microscopic observations do not allow differentiation of leukocyte subpopulations, differential leukocyte counts in the peripheral blood samples taken before and in the time course after injection of oxLDL suggest that all leukocyte subpopulations were likewise affected by the adhesion promoting action of oxLDL (Fig. 4) . This impression is further substantiated by the electron microscopic studies, in which the spectrum of adherent leukocytes correlated well with the differential leukocyte counts in the peripheral blood with no specific preference for monocytes (Fig. 4) .
The presence and role ofPMNs and lymphocytes in atherogenesis therefore remains a matter of speculation (26) . One possible concept is that leukotrienes, metabolites of arachidonic acid generated in the 5-lipoxygenase pathway and released from activated PMNs after their adhesion to the vascular endothelium, contribute to the pathophysiologic sequelae of atherogenesis by propagating the chemotactic accumulation of further leukocytes (8) and by impairing the vascular integrity (9) . This concept could also explain the localization of adherent leukocytes at sites of enhanced permeability (3) and the direct permeabilizing action ofoxLDL on the vascular endothelium (27) .
The pretreatment ofthe animals with the selective inhibitor ofleukotriene biosynthesis, MK-886 (1 1 Our idea that oxLDL may promote atherogenesis through the action of leukotrienes is further supported by the demonstration of leukotriene generation in atherosclerotic plaques (31) and by the finding that lipoxygenase inhibitors effectively prevent the uptake ofcholesteryl esters into monocytes/macrophages (32) .
The mechanism by which oxLDL provoked leukocyte activation and adhesion to the endothelium is incompletely understood. Ishikawa (33) demonstrated that oxLDL stimulates the inositolphosphate turnover in leukocytes to synthesize inositoltriphosphate, a second messenger capable of releasing Ca++ from intracellular stores. Furthermore, oxLDL acts as a Ca++ ionophore, stimulating the influx of extracellular Ca++ (34) . Both mechanisms lead to the increase in intracellular Ca++ with subsequent 5-lipoxygenase activation. Another mechanism by which oxLDL may promote leukocyte adhesion is the inhibition of prostacyclin generation (35) in endothelial cells. Since prostacyclin defends against leukocyte adherence to the vascular endothelium (36) , it is conceivable that oxLDL-induced reduction ofprostacyclin synthesis may promote leukocyte adherence.
Systemic administration of oxLDL creates no chemotactic gradient between the endothelial lining and circulating blood leukocytes. We therefore suggest that oxLDL may not act as a chemoattractant but via the upregulation of adherence receptors, either directly as shown for HLA-DR molecules (6) or indirectly via LTB4-mediated upregulation ofCD1 l/CD1 8 adherence receptors (37). This would also explain why not only monocytes, but also PMNs and lymphocytes that also bear this receptor on their surface readily interact with the endothelium following the administration of oxLDL (Figs. 3 and 4) .
It has been suggested that atherogenesis in response to vascular injury shares many pathophysiologic mechanisms with the inflammatory response, like leukocyte adhesion and emigration, and increased microvascular permeability (38) . Although caution should be exercised in extrapolating the results from our acute experiments to the chronic process of atherogenesis, the identification of the involvement of leukotrienes in leukocyte/endothelium interaction as the initial event in atherogenesis stresses the similarities between the two processes and may open the way for novel therapeutic strategies aimed at the prevention of lesion inception and lesion progression.
